BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26395328)

  • 1. Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis.
    Hemkens LG; Ewald H; Santini-Oliveira M; Bühler JE; Vuichard D; Schandelmaier S; Stöckle M; Briel M; Bucher HC
    HIV Clin Trials; 2015 Oct; 16(5):178-89. PubMed ID: 26395328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Communication: Higher Tenofovir Concentrations in Hair Are Associated with Decreases in Viral Load and Not Self-Reported Adherence in HIV-Infected Adolescents with Second-Line Virological Treatment Failure.
    Chawana T; Nhachi C; Nathoo K; Ngara B; Okochi H; Louie A; Kuncze K; Katzenstein D; Metcalfe J; Gandhi M
    AIDS Res Hum Retroviruses; 2021 Oct; 37(10):748-750. PubMed ID: 33499754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy.
    Kalayjian RC; Albert JM; Cremers S; Gupta SK; McComsey GA; Klingman KL; Fichtenbaum CJ; Brown TT; Taiwo BO;
    AIDS; 2018 Nov; 32(17):2517-2524. PubMed ID: 30134291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of adverse coronavirus disease 2019 outcomes for people living with HIV.
    Mellor MM; Bast AC; Jones NR; Roberts NW; Ordóñez-Mena JM; Reith AJM; Butler CC; Matthews PC; Dorward J
    AIDS; 2021 Mar; 35(4):F1-F10. PubMed ID: 33587448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Adverse Effects of Tenofovir Containing Regimens in HIV-Infected Children and Adolescents in North India.
    Kumar R; Singh MV; Shrivastava A; Yadav RK; Siddiqui SA; Sachan R; Maurya M; Mishra N; Shukla SK; Sonkar M
    Indian Pediatr; 2024 Apr; 61(4):337-342. PubMed ID: 38449277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Tenofovir Use With Risk of Incident Heart Failure in HIV-Infected Patients.
    Chen R; Scherzer R; Hsue PY; Jotwani V; Estrella MM; Horberg MA; Grunfeld C; Shlipak MG
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials.
    Ngongondo M; Ritz J; Hughes MD; Matoga M; Hosseinipour MC;
    PLOS Glob Public Health; 2024; 4(1):e0002648. PubMed ID: 38175824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and Calcium Supplementation Reverses Tenofovir-Caused Bone Mineral Density Loss in People Taking ART or PrEP: A Systematic Review and Meta-Analysis.
    Bi X; Liu F; Zhang X; Wang H; Ye Z; Yun K; Huang X; Ding H; Geng W; Xu J
    Front Nutr; 2022; 9():749948. PubMed ID: 35433788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing bone mineral density in children and adolescents living with HIV and on treatment with tenofovir disoproxil fumarate: a systematic review.
    Gusmão MBF; Oliveira VV; Santos NMDS; Melo LC
    Rev Paul Pediatr; 2023; 42():e2023042. PubMed ID: 37971172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis.
    Eyawo O; Brockman G; Goldsmith CH; Hull MW; Lear SA; Bennett M; Guillemi S; Franco-Villalobos C; Adam A; Mills EJ; Montaner JSG; Hogg RS
    BMJ Open; 2019 Sep; 9(9):e025874. PubMed ID: 31551371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria is common among HIV patients: what are we missing?
    Antonello VS; Antonello IC; Herrmann S; Tovo CV
    Clinics (Sao Paulo); 2015 Oct; 70(10):691-5. PubMed ID: 26598082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings.
    Innes S; Patel K
    Curr Opin HIV AIDS; 2018 May; 13(3):187-195. PubMed ID: 29432231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition counselling and clinical outcomes in HIV: A systematic review and meta-analysis.
    Okusanya TR; Okoka EM; Kuyebi MA; Oyadiran OT; Kowe T; Noor RA; Omotayo MO; Abioye AI
    HIV Med; 2024 Apr; 25(4):462-478. PubMed ID: 38158600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.
    Wohl D; Oka S; Clumeck N; Clarke A; Brinson C; Stephens J; Tashima K; Arribas JR; Rashbaum B; Cheret A; Brunetta J; Mussini C; Tebas P; Sax PE; Cheng A; Zhong L; Callebaut C; Das M; Fordyce M;
    J Acquir Immune Defic Syndr; 2016 May; 72(1):58-64. PubMed ID: 26829661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Toxicity of Concomitant Exposure to Tenofovir and Inhibitors of Tenofovir's Renal Efflux Transporters in Patients Infected With HIV Type 1.
    Rokx C; Alshangi H; Verbon A; Zietse R; Hoorn EJ; Rijnders BJ
    J Infect Dis; 2016 Feb; 213(4):561-8. PubMed ID: 26401025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention.
    Murnane PM; Brown ER; Donnell D; Coley RY; Mugo N; Mujugira A; Celum C; Baeten JM;
    Am J Epidemiol; 2015 Nov; 182(10):848-56. PubMed ID: 26487343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial.
    Paton NI; Stöhr W; Arenas-Pinto A; Fisher M; Williams I; Johnson M; Orkin C; Chen F; Lee V; Winston A; Gompels M; Fox J; Scott K; Dunn DT;
    Lancet HIV; 2015 Oct; 2(10):e417-26. PubMed ID: 26423649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.
    Onakpoya IJ; Hayward G; Heneghan CJ
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011530. PubMed ID: 26408070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent-based thrombectomy versus intravenous tissue plasminogen activator in acute ischaemic stroke: A systematic review and meta-analysis.
    Grech R; Schembri M; Thornton J
    Interv Neuroradiol; 2015 Dec; 21(6):684-90. PubMed ID: 26490828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Early Hypertension Control after Ischaemic Stroke on the Outcome: A Meta-Analysis.
    Liu S; Li C; Li T; Xiong J; Zhao X
    Cerebrovasc Dis; 2015; 40(5-6):270-8. PubMed ID: 26488895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.